Transarterial Chemoembolization Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients with Hepatocellular Carcinoma (IDADOX)
Latest Information Update: 09 Jan 2025
At a glance
- Drugs Idarubicin (Primary) ; Doxorubicin; Ethiodized oil
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms IDADOX
Most Recent Events
- 07 Jan 2025 Planned End Date changed from 1 Dec 2025 to 30 Jun 2026.
- 07 Jan 2025 Planned primary completion date changed from 1 Dec 2025 to 31 Dec 2025.
- 01 Mar 2024 Trial design presented in the Cardiovascular and Interventional Radiology.